Moderna vaccine

US Hospitals Anticipate The Approval Of The Second Vaccine

  • COVID-19 hospitalizations rose to record heights for a 19th straight day, with nearly 113,000 coronavirus patients counted in U.S.
  • The virus has claimed over 311,000 lives in the United States to date, and health experts have warned of a deepening crisis this winter.
  • The initial 2.9 million doses of the Pfizer/BioNTech vaccine began shipping on Sunday and were still making their way to hospitals across the country.

An unrelenting U.S. coronavirus surge pushed besieged hospitals further...

https://mfame.guru/us-hospitals-anticipate-the-approval-of-the-second-vaccine/

Vaccinated People Still At Risk Of Spreading COVID, Says Study

The new Covid-19 vaccines from Pfizer and Moderna seem to be remarkably good at preventing serious illness. But it’s unclear how well they will curb the spread of the coronavirus, reports NY Times.

Silent spreaders still on the loose

That’s because the Pfizer and Moderna trials tracked only how many vaccinated people became sick with Covid-19. That leaves open the possibility that some vaccinated people get infected without developing symptoms, and could then silently transmit the virus —...

https://mfame.guru/vaccinated-people-still-at-risk-of-spreading-covid-says-study/

A Surge In Cases During The Holiday Season In The US

  • A record-high 96,039 Covid-19 patients were hospitalized in the US as of Monday evening.
  • The intensive care unit bed capacity in the state might reach 112% by Christmas Eve.
  • Health experts are asking the 1 million travelers dispersing across the country gathered with people outside their households over Thanksgiving week to get tested for Covid-19.
  • November has been a month of unprecedented Covid-19 surge. More than 30% of all cases ever reported in the US happened just this month.

As the...

https://mfame.guru/a-surge-in-cases-during-the-holiday-season-in-the-us/

Will Trials Alter the 90% Efficacy of Pfizer Vaccine?

  • Pfizer and BioNTech said they had identified 94 cases of COVID-19 among 43,538 trial participants.
  • The split of cases between the groups suggested that the vaccine was more than 90% effective at preventing disease.
  • The trial will continue until a total of 164 COVID-19 cases are detected, so initial estimates of the vaccine’s effectiveness could change.
  • Pfizer and BioNTech reported that 42% of participants had racially and ethnically diverse backgrounds.

Scientists have greeted with cautious...

https://mfame.guru/will-trials-alter-the-90-efficacy-of-pfizer-vaccine/

+ More
Join Our Newsletter
Enter your email to receive a weekly round-up of shipping news.
icon
By subscribing, you agree with our privacy policy and our terms of service.